DexCom (DXCM) Tops Q3 EPS by 26c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $71.54 +1.50%
EPS Growth %: +27.1%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
ORPB, ONEG, NDLS, More
EPS Growth %: +27.1%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
ORPB, ONEG, NDLS, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.89, $0.26 better than the analyst estimate of $0.63. Revenue for the quarter came in at $650.2 versus the consensus estimate of $618.36 million.
GUIDANCE:
DexCom sees FY2021 revenue of $2.425-2.45 billion, versus the consensus of $2.4 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gentex Corporation (GNTX) Tops Q2 EPS by 8c ; Offers Guidance
- American Express down 2% in premarket trade after Q2 revenue miss offsets EPS beat
- HSBC starts SpaceX at Hold, sees execution risks tempering long-term AI ambitions
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
